Exenatide in type 2 diabetes : treatment effects in clinical studies and animal study dataGALLWITZ, B.International journal of clinical practice (Esher). 2006, Vol 60, Num 12, pp 1654-1661, issn 1368-5031, 8 p.Article

Global risk management in type 2 diabetes: Blood glucose, blood pressure, and lipids: Update on the background of the current guidelinesCLEMENS, A; SIEGEL, E; GALLWITZ, B et al.Experimental and clinical endocrinology & diabetes. 2004, Vol 112, Num 9, pp 493-503, issn 0947-7349, 11 p.Article

Binding of GLP-1(7-36)amide analogues and GLP-1/GIP hybrid peptides to RINm5F insulinoma cellsGALLWITZ, B; WITT, M; SCHMIDT, W. E et al.Digestion. 1993, Vol 54, Num 6, issn 0012-2823, p. 345Conference Paper

Are There Gender-Specific Differences Concerning Quality of Life in Treated Acromegalic Patients?PSARAS, T; HONEGGER, J; GALLWITZ, B et al.Experimental and clinical endocrinology & diabetes. 2011, Vol 119, Num 5, pp 300-305, issn 0947-7349, 6 p.Article

Adding liraglutide to oral antidiabetic drug therapy: onset of treatment effects over timeGALLWITZ, B; VAAG, A; FALAHATI, A et al.International journal of clinical practice (Esher). 2010, Vol 64, Num 2, pp 267-276, issn 1368-5031, 10 p.Article

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and its responsible for their degradation in human serumMENTLEIN, R; GALLWITZ, B; SCHMIDT, W. E et al.European journal of biochemistry (Print). 1993, Vol 214, Num 3, pp 829-835, issn 0014-2956Article

Cushing's Disease Associated with both Pituitary Microadenoma and Corticotroph HyperplasiaHAAP, M; GALLWITZ, B; MEYERMANN, R et al.Experimental and clinical endocrinology & diabetes. 2009, Vol 117, Num 6, pp 289-293, issn 0947-7349, 5 p.Article

Impact of postprandial and fasting glucose concentrations on HbA_1c in patients with type 2 diabetesSCHERNTHANER, G; GUERCI, B; GALLWITZ, B et al.Diabetes & metabolism. 2010, Vol 36, Num 5, pp 389-394, issn 1262-3636, 6 p.Article

A common genetic variant in WFS1 determines impaired glucagon-like peptide-1-induced insulin secretionSCHÄFER, S. A; MÜSSIG, K; STAIGER, H et al.Diabetologia (Berlin). 2009, Vol 52, Num 6, pp 1075-1082, issn 0012-186X, 8 p.Article

Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms. CommentaryNAUCK, M. A; MEIER, J. J; T'HART, L. M et al.Diabetologia (Berlin). 2007, Vol 50, Num 12, issn 0012-186X, 2413-2416, 2443-2450 [12 p.]Article

Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humansMEIER, J. J; GETHMANN, A; GÖTZE, O et al.Diabetologia (Berlin). 2006, Vol 49, Num 3, pp 452-458, issn 0012-186X, 7 p.Article

Insulin secretion defects in liver cirrhosis can be reversed by glucagon-like peptide-1SIEGEL, E. G; SEIDENSTÜCKER, A; GALLWITZ, B et al.Journal of endocrinology. 2000, Vol 164, Num 1, pp 13-19, issn 0022-0795Article

Comparison of the effect of native glucagon-like peptide I and dipeptidyl peptidase IV-resistant analogues on insulin release from rat pancreatic isletsSIEGEL, E. G; SCHARF, G; GALLWITZ, B et al.European journal of clinical investigation. 1999, Vol 29, Num 7, pp 610-614, issn 0014-2972Article

Differentialdiagnose granulomatöser Erkrankungen : Epitheloidzellgranulome im Darm und in der Leber bei Morbus Crohn ? = Differential diagnosis of granulomatous disease: intestinal, and hepatic noncaseating granulomas in Crohn's diseaseGALLWITZ, B; JÄNIG, U; FÖLSCH, U. R et al.Zeitschrift für Gastroenterologie. 1994, Vol 32, Num 5, pp 252-255, issn 0044-2771Conference Paper

Lymph Node Gastrinoma in Multiple Endocrine Neoplasia Type 1 -a Diagnostic ChallengeMÜSSIG, K; WEHRMANN, M; HORGER, M et al.Experimental and clinical endocrinology & diabetes. 2008, Vol 116, Num 9, pp 554-557, issn 0947-7349, 4 p.Article

Is impairment of ischaemic preconditioning by sulfonylurea drugs clinically important?MEIER, J. J; GALLWITZ, B; SCHMIDT, W. E et al.Heart (London 1996). 2004, Vol 90, Num 1, pp 9-12, issn 1355-6037, 4 p.Article

Appetitregulation durch Ghrelin -ein neues neuroendokrines gastrales Peptidhormon der Gut-Brain-Achse = Appetite regulation by Ghrelin - a novel neuro-endocrine gastric peptidhormone in the gut-brain-axisHAGEMANN, D; MEIER, J. J; GALLWITZ, B et al.Zeitschrift für Gastroenterologie. 2003, Vol 41, Num 9, pp 929-936, issn 0044-2771, 8 p.Article

Isolation and primary structure of pituitary human galanin, a 30-residue nonamidated neuropeptideSCHMIDT, W.E; KRATZIN, H; ECKART, K et al.Proceedings of the National Academy of Sciences of the United States of America. 1991, Vol 88, Num 24, pp 11435-11439, issn 0027-8424Article

Demographic Factors and the Presence of Comorbidities do not Promote Early Detection of Cushing's Disease and AcromegalyPSARAS, T; MILIAN, M; HATTERMANN, V et al.Experimental and clinical endocrinology & diabetes. 2011, Vol 119, Num 1, pp 21-25, issn 0947-7349, 5 p.Article

Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trialGÖKE, B; GALLWITZ, B; ERIKSSON, J et al.International journal of clinical practice (Esher). 2010, Vol 64, Num 12, pp 1619-1631, issn 1368-5031, 13 p.Article

Medical Antihyperglycaemic Treatment of Type 2 Diabetes Mellitus ^*: Update of the evidence-based guideline of the German Diabetes AssociationMATTHAEI, S; BIERWIRTH, R; SCHERNTHANER, G et al.Experimental and clinical endocrinology & diabetes. 2009, Vol 117, Num 9, pp 522-557, issn 0947-7349, 36 p.Article

The risk allele load accelerates the age-dependent decline in beta cell functionHAUPT, A; STAIGER, H; SCHÄFER, S. A et al.Diabetologia (Berlin). 2009, Vol 52, Num 3, pp 457-462, issn 0012-186X, 6 p.Article

Effect of human pancreastatin peptide (hP-16) on oral glucose tolerance in manSIEGEL, E. G; GALLWITZ, B; FÖLSCH, U. R et al.Experimental and clinical endocrinology & diabetes. 1998, Vol 106, Num 3, pp 178-182, issn 0947-7349Article

Characterization of an amidated form of pancreatic polypeptide from the daddy sculpin (Cottus scorpius)CONLON, J. M; SCHMIDT, W. E; GALLWITZ, B et al.Regulatory peptides. 1986, Vol 16, Num 3-4, pp 261-268, issn 0167-0115Article

Pegvisomant treatment in gigantism caused by a growth hormone-secreting giant pituitary adenomaMÜSSIG, K; GALLWITZ, B; HONEGGER, J et al.Experimental and clinical endocrinology & diabetes. 2007, Vol 115, Num 3, pp 198-202, issn 0947-7349, 5 p.Article